AVH guy was on ****** this morning.
talked about how they are finding it hard to get effective sales under Covid conditions.
something along the lines of they expect to hold their 25m revenue and maybe grow "a little"
I know that their tech works on a different level of burn/injury
but I am thinking their difficulty in growing business in sales may be reflective how easy the BTM is to use? which make digital sales more likely due to not needing as much sales rep support or clinical support?
what are other people's thoughts on this?
AVH guy was on ****** this morning. talked about how they are...
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.35 |
Change
-0.040(1.67%) |
Mkt cap ! $1.623B | |||
| Open | High | Low | Value | Volume |
| $2.41 | $2.41 | $2.34 | $1.491M | 631.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3816 | $2.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.36 | 8900 | 2 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |